My Ultimate Sign-in System Made Me Invincible

After the volunteers were settled in their quarters, the observers followed. They were from the same countries as the volunteers.

They came through the same corridor, with the Synths leading them.

The observers from Mexico — a physician from the National Institute of Medical Sciences and Nutrition and two representatives from COFEPRIS, Mexico’s federal health regulator — were escorted to their designated accommodation first.

The Polish delegation followed: a physician from the Medical University of Warsaw, a public health specialist from the Chief Sanitary Inspectorate, and a legal observer from the Ministry of Foreign Affairs.

Their rooms were on a separate corridor from the volunteers, as the observer access framework had specified.

Most of them stood at the transparent wall for a moment before doing anything else.

One of the COFEPRIS representatives set her bag down without unpacking it and stood with her notebook against her chest, looking at the common space below and the high ceiling above and the base extending in every direction around her.

Two hours after they had been shown to their quarters, Nova appeared at the residential corridor.

She walked it once without speaking, stopping briefly at each door. The doors opened as she reached them. She said it was time.

The volunteers came out one by one. The staff were already positioned, the medical cots waiting in the corridor for those who needed them.

The Synths collected the observers from their corridor and brought them to meet the group at the elevator.

They rode down together in silence. The volunteers and the observers occupied the same space without speaking to each other, separated by role and by the weight of what each group was moving toward, but sharing the same corridor, the same elevator, the same steady sourceless light.

The trial section of the base was one level below the residential floor.

The elevator opened onto a corridor that was different from anything they had seen yet. Wider than the residential level, the ceiling higher, the proportions deliberate in a way that communicated function without coldness.

The floor was a slightly different material underfoot. The lighting was the same steady white but brighter here, calibrated for work rather than rest.

Along both sides of the corridor, doors were set at regular intervals. Each one bore a number, flush to the wall, clean and simple.

Nova led the group down the corridor without hurrying. And the staff moved alongside the volunteers.

At each numbered door, Nova stopped and the relevant staff member guided their volunteer through it.

The rooms beyond were not what the observers had expected.

The COFEPRIS physician, standing in the corridor as the doors opened one by one, had spent fifteen years evaluating clinical environments.

She had assessed field hospitals, research facilities, underfunded rural clinics, and the gleaming private institutions that bore no resemblance to where most of her patients received care.

She had a framework for clinical spaces that she had built across those fifteen years and refined into something she trusted.

She looked through the open door of the nearest trial room and the framework did not apply.

The room was generously large. The bed was low and wide, the surface already adjusted to the incoming volunteer’s documented preferences from the intake scan.

The monitoring station was integrated into the wall, its display currently showing the volunteer’s baseline data from this morning’s assessment. It was clean and organized and readable even from the doorway.

There was a chair beside the bed for the family member. A second chair further back for the staff member. A small table between them with water already on it.

The window on the far wall looked out into the corridor. One-way glass.

That was where the observers would stand.

Nova turned to the observer delegations at the end of the corridor.

“You will observe from the corridor windows,” she said. “The glass is one-way. Volunteers cannot see you. You will have a clear sightline to the monitoring display and to the bed. You may not enter the rooms. You may not direct or address the staff. If you have a question about what you are observing, note it and bring it to me after the session.”

She looked at them for a moment, then turned and walked to the first door.

The staff guided the last volunteer through and the doors closed.

The observers moved to their windows and stood there, notebooks open, pens ready, looking through the glass at the rooms beyond and the people inside them and the beds where the most significant medical event in human history was about to begin in the most ordinary possible way,  with one person lying down, one nurse sitting beside them, a document being read aloud in a quiet room.

The assessment came first. Dr. Park and Thomas worked through Diego’s room together, the MedScan confirming what the airport scan had already shown, the data updating on the monitoring display in real time.

Diego sat upright on the bed, Marco beside him, watching the holographic readout with rapt attention.

When the assessment was complete, Thomas sat down across from Diego and Marco and opened the consent document on his tablet.

“I’m going to read this to you in full,” he said. “All of it. Take as long as you need at any point.”

Marco translated and Diego nodded.

Then Thomas began reading.

NOVA MEDICAL NANITES CLINICAL TRIAL

Volunteer Consent Document

Volunteer 11

You are about to receive Nova Medical Nanites as part of Nova Technologies’ clinical trial. Before deployment begins, we need your informed and voluntary consent. Please listen carefully to everything in this document. You may ask questions at any point.

What the nanites are:

Nova Medical Nanites are microscopic biological machines designed to identify and repair damage, disease, and dysfunction within the human body. They operate by reading your body’s biological state, identifying what is wrong, and correcting it through targeted intervention at the cellular and tissue level.

What will happen to you:

The nanites will be introduced into your body through a single injection. Once active, they will begin assessing your condition and initiating repair processes. This happens continuously, without further intervention from medical staff. You will be monitored throughout the entire active phase.

What you may feel:

Responses vary between individuals and conditions. You might feel warmth, pressure, or tingling at the sites of active repair. You might also feel nothing at all. If you experience discomfort at any point, tell a staff member immediately. You will never be left without someone within reach.

Your safety:

You are not in danger. The nanites are designed to do no harm. You have Emergency Override Authorization active from the moment of deployment — this means the nanites will respond automatically to any life-threatening event within seconds, before any human response would be possible. You are safer inside this facility during the active phase than you would be in any hospital on Earth.

Your privacy:

All data collected during your trial is private. It will not be published, shared, or disclosed to any person or institution without your explicit permission. You will receive a complete copy of your personal trial data when the trial concludes. That data belongs to you.

Observer access:

Qualified observers from international institutions are present at this facility. They may observe trial proceedings from designated areas. They will not have access to your personal medical data without your explicit consent. You may decline observer presence in your room at any time.

Withdrawal:

You may withdraw from the trial at any point before nanite deployment begins, without penalty of any kind. After deployment begins, withdrawal requires a medical assessment to determine the safest method of suspending nanite activity. You will not be pressured to continue. Withdrawal does not affect your access to the Lucid device or Essential Care subscription provided as part of your trial package.

Livestream:

Nova Technologies may conduct a public livestream of portions of the clinical trial. Participation is entirely optional. If you consent to livestream inclusion, your image and voice may be broadcast publicly during designated trial moments. If you do not consent, you will not appear in any broadcast at any time. Your care is identical regardless of your choice.

By signing this document, you confirm that:

— You have heard and understood everything in this document

— You are consenting voluntarily and without pressure

— You understand you may ask questions or withdraw at any time

— You are ready to begin

***

Thomas finished reading and looked up.

Diego had been listening throughout, his eyes moving between Thomas and Marco, tracking the translation as it came. His mother sat beside the bed with her hands folded. His brother stood near the wall.

Thomas set the tablet down. “Do you have any questions?”

Marco translated.

Diego shook his head.

“Then I’ll ask you to confirm each section,” Thomas said. “We go through them one at a time. You tell me yes or no.”

They worked through the document in sequence. Diego confirmed each section without hesitation until Thomas reached the livestream clause.

Diego listened to Marco translate it. He looked at his mother, then he looked at Thomas and said something.

“He says yes,” Marco said. “He wants people to see.”

Thomas made the notation and continued to the final confirmation.

Diego signed.

***

In Maya’s room, the nurse assigned to her, read the same document aloud, with Rosa sitting beside the bed and Maya listening from the pillow where she had been resting since they arrived.

Maya had questions. She asked what the itching meant, whether it would hurt, whether her mother could stay in the room the whole time.

The nurse answered each one without shortening her answers. Maya listened carefully and asked a follow-up to the third question that the nurse had not anticipated, and answered it correctly, and Maya nodded and said she understood.

They reached the livestream section.

Rosa’s posture changed before the nurse had finished the sentence.

“No,” Rosa said.

Adaeze looked up from the tablet.

Rosa had her hand on Maya’s arm. “I don’t want her face online. She’s nine. She doesn’t know what that means for the rest of her life. People will find her. They will use her. They will make her into something she doesn’t have a say in.” Her voice was steady but the nurse could sense the intense worry in her voice. “She is not a story for other people.”

The nurse set the tablet down. “It’s optional,” she said. “Completely optional. Your decision is your decision and it changes nothing about Maya’s care. Nothing.”

Rosa looked at her for a moment.

“Nothing changes?” she said.

“Nothing,” the nurse said. “She receives exactly the same treatment. The same attention. The same everything. The livestream section is the only part of this document where your answer affects anything outside this room.”

Rosa’s shoulders came down slightly. She looked at Maya.

Maya was watching her mother with curiosity, as she understood the decision was not hers to make and was waiting to see what the person who loved her most would choose.

Rosa looked at the nurse. “We won’t be giving consent.”

The nurse made the notation.

“Thank you for explaining it,” Rosa said.

The nurse smiled. “Thank you for asking the right questions.”

Maya reached up and took her mother’s hand.

***

By the time the last consent document was completed, three volunteers had agreed to the livestream. Volunteer 11 — Diego. Volunteer 41. Volunteer 42.

The others had declined, for reasons that were their own and required no justification.

The Synths arrived quietly.

They came through the room doors in pairs — each one dressed in dark scrubs. And each Synth carried a metal tray, held level, with both hands.

On each tray was one injector.

The nurse in Diego’s room was the first to reach for hers.

She picked it up carefully, her fingers closing around the grip the way you held something you had trained with but never used for real.

The injector was slim and longer than a standard medical syringe, with a body machined from something that wasn’t quite metal and wasn’t quite glass.

It was a material that was slightly warm to the touch and caught the light without glare. The grip section was textured for purchase. The delivery mechanism sat at the tip, recessed and smooth, designed to be nearly painless at the point of entry.

At the center of the injector, enclosed in a clear cylindrical chamber, was the fluid.

It was black liquid that absorbed light rather than reflecting it, with a depth to it that made the chamber look larger than it was.

It moved when the injector tilted, slow and dense, and it had nothing in common with any injectable the nurse had handled in fourteen years of clinical work.

She looked at it for a moment, then she exhaled softly, it was the first time she was holding the injector.

She turned to Diego, who was watching her face rather than the injector.

Marco said nothing. He had understood, somewhere in the past hour, that there were moments that didn’t need translation.

The nurse brought the injector to Diego’s shoulder, the delivery site already prepped, cleaned and marked. She positioned it correctly, held it steady, and in one fluid motion, she depressed the mechanism.

The black fluid emptied completely in a single shot.

She withdrew the injector. The site showed nothing beyond the entry point, clean and small, already closing.

Diego sat very still. Then he looked down at where his legs were not.

Then up at Marco, and he spoke quietly.

Marco listened. Then he said, in a voice that was not entirely steady: “He says his legs are itching.”